CurtisJL. Understanding COPD etiology, pathophysiology, and definition. Respir Care, 2023; 68(7):859–870; doi: 10.4187/respcare.10873
2.
ManninoDM, RobertsMH, MapelDW, et al.National and local direct medical cost burden of COPD in the United States from 2016 to 2019 and projections through 2029. Chest, 2024; 165(5):1093–1106; doi: 10.1016/j.chest.2023.11.040
PleasantsRA, DonohueJF. Current perspectives of pharmacotherapies for COPD. Respir Care, 2023; 68(7):927–938; doi: 10.4187/respcare.10952
5.
CrinerGJ. Surgical and interventional approaches in COPD. Respir Care, 2023; 68(7):939–960; doi: 10.4187/respcare.10825
6.
MosherCL, NannaMG, JawitzOK, et al.Cost-effectiveness of pulmonary rehabilitation among us adults with chronic obstructive pulmonary disease. JAMA Netw Open, 2022; 5(6):e2218189; doi: 10.1001/jamanetworkopen.2022.18189. Erratum in: JAMA Netw Open 2022;5(7):e2225391; doi: 10.1001/jamanetworkopen.2022.25391
7.
NathaniA, NanahA, Al-JaghbeerMJ, et al.Multidisciplinary evaluation for COPD management. Respir Care, 2025; 70(7):810–820; doi: 10.1089/respcare.12345
8.
FishmanA, MartinezF, NaunheimK, et al.; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med, 2003; 348(21):2059–2073; doi: 10.1056/NEJMoa030287
